相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advanced Nanoengineering Approach for Target-Specific, Spatiotemporal, and Ratiometric Delivery of Gemcitabine-Cisplatin Combination for Improved Therapeutic Outcome in Pancreatic Cancer
Mubin Tarannum et al.
SMALL (2022)
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
Luman Liu et al.
THERANOSTICS (2022)
Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics
Eun-Jeong Won et al.
PHARMACEUTICS (2022)
Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer
Kathleen M. McAndrews et al.
LIFE SCIENCE ALLIANCE (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
Yang Wu et al.
FRONTIERS IN ONCOLOGY (2021)
Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts
Huiqin Liu et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Tailor-Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma
Xi Hu et al.
ADVANCED SCIENCE (2021)
Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance
Yalan Deng et al.
NATURE COMMUNICATIONS (2021)
Nanotechnology and pancreatic cancer management: State of the art and further perspectives
Damiano Caputo et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Targeting KRAS in pancreatic cancer: new drugs on the horizon
Sahar F. Bannoura et al.
CANCER AND METASTASIS REVIEWS (2021)
Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
Vida Karimnia et al.
CANCERS (2021)
KRAS mutation: from undruggable to druggable in cancer
Lamei Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo-immunotherapy
Mingxia Jiang et al.
NANOSCALE (2021)
The KRAS(G12C) Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin et al.
CANCER DISCOVERY (2020)
Refined TNM-staging for pancreatic adenocarcinoma - Real progress or much ado about nothing?
Marcus Roalso et al.
EJSO (2020)
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Cheng Qin et al.
MOLECULAR CANCER (2020)
Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
Yukun Huang et al.
NATURE COMMUNICATIONS (2020)
Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
Prasenjit Dey et al.
CANCER DISCOVERY (2020)
Immunotherapy for pancreatic cancer: A 2020 update
Dimitrios Schizas et al.
CANCER TREATMENT REVIEWS (2020)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
Yunzhen Qian et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes
Alsya J. Affandi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy
Xiaofei Xin et al.
SCIENCE ADVANCES (2020)
Biodegradable Silica-Based Nanoparticles with Improved and Safe Delivery of Protoporphyrin IX for the In Vivo Photodynamic Therapy of Breast Cancer
Zachary K. Lyles et al.
ADVANCED THERAPEUTICS (2020)
Blocking Ras inhibition as an antitumor strategy
Nagore I. Marin-Ramos et al.
SEMINARS IN CANCER BIOLOGY (2019)
Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin
Wei Chen et al.
BIOMATERIALS (2019)
Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer
Fan Lei et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice
B. Y. Yan et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt
Mourad Sanhaji et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer
Sheema Khan et al.
BIOMATERIALS (2019)
Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer
Matteo Ligorio et al.
CELL (2019)
Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer
Man Li et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy
Hua Huang et al.
NANO LETTERS (2019)
Photodynamic therapy for solid tumors: A review of the literature
Rebecca L. Yanovsky et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2019)
Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
Mengying Hu et al.
NATURE COMMUNICATIONS (2019)
Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors
Assaf Zinger et al.
ACS NANO (2019)
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
Michael Orth et al.
RADIATION ONCOLOGY (2019)
MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
Afra Z. Daoud et al.
BMC CANCER (2019)
Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRASG12C Inhibitor, Evaluated in NSCLC
R. Govindan et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Gemcitabine Combination Nano Therapies for Pancreatic Cancer
Kamalika Samanta et al.
PHARMACEUTICS (2019)
Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma
Giulia Brachi et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Mapping Physical Tumor Microenvironment and Drug Delivery
Hadi T. Nia et al.
CLINICAL CANCER RESEARCH (2019)
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
Divya Thomas et al.
MOLECULAR CANCER (2019)
Targeting the Oncogene KRAS Mutant Pancreatic Cancer by Synergistic Blocking of Lysosomal Acidification and Rapid Drug Release
Chao Kong et al.
ACS NANO (2019)
Role of the tumor microenvironment in pancreatic cancer
Takashi Murakami et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2019)
Hierarchical assembly of hyaluronan coated albumin nanoparticles for pancreatic cancer chemoimmunotherapy
Ying Hu et al.
NANOSCALE (2019)
Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy
Yi-Fan Zhang et al.
CHINESE CLINICAL ONCOLOGY (2019)
Biodegradable, pH-Sensitive Hollow Mesoporous Organosilica Nanoparticle (HMON) with Controlled Release of Pirfenidone and Ultrasound-Target-Microbubble-Destruction (UTMD) for Pancreatic Cancer Treatment
Feng Gao et al.
THERANOSTICS (2019)
Dual Controlled Delivery of Gemcitabine and Cisplatin Using Polymer-Modified Thermosensitive Liposomes for Pancreatic Cancer
Mandana Emamzadeh et al.
ACS APPLIED BIO MATERIALS (2019)
Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy
Jun Zhao et al.
BIOMATERIALS (2018)
Personalized RNA Medicine for Pancreatic Cancer
Maud-Emmanuelle Gilles et al.
CLINICAL CANCER RESEARCH (2018)
Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer
Claire Vennin et al.
GASTROENTEROLOGY (2018)
Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
Yiyin Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Chaperonin-GroEL as a Smart Hydrophobic Drug Delivery and Tumor Targeting Molecular Machine for Tumor Therapy
Yi Yuan et al.
NANO LETTERS (2018)
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum et al.
NATURE COMMUNICATIONS (2018)
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jaison Jeevanandam et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2018)
Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers
Limei Shen et al.
ACS NANO (2018)
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma
Michele Reni et al.
EUROPEAN JOURNAL OF CANCER (2018)
Tumor microenvironment participates in metastasis of pancreatic cancer
Bo Ren et al.
MOLECULAR CANCER (2018)
Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem
Xuexiang Han et al.
NATURE COMMUNICATIONS (2018)
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
Derya Kabacaoglu et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Potential of CAR T Cell Therapy in Pancreatic Cancer
Mehmet Akce et al.
FRONTIERS IN IMMUNOLOGY (2018)
Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo
Deby F. Mardhian et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling
Zhengle Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis
Sung-Won Shin et al.
MARINE DRUGS (2018)
Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype
Mirna Swayden et al.
HELIYON (2018)
Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors
Lei Miao et al.
CANCER RESEARCH (2017)
Biodistribution of Self-Assembling Polymer-Gemcitabine Conjugate after Systemic Administration into Orthotopic Pancreatic Tumor Bearing Mice
Krishna Kattel et al.
MOLECULAR PHARMACEUTICS (2017)
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
Aleksandra Adamska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer
Goutam Mondal et al.
MOLECULAR PHARMACEUTICS (2017)
Cancer drug delivery in the nano era: An overview and perspectives (Review)
Zhen Li et al.
ONCOLOGY REPORTS (2017)
Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer
Byunghee Yoo et al.
SCIENTIFIC REPORTS (2017)
Pancreatic Cancer Chemoresistance to Gemcitabine
Manoj Amrutkar et al.
CANCERS (2017)
KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
Jonas Cicenas et al.
CANCERS (2017)
Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer
Lei Miao et al.
ACS NANO (2017)
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer
Surendra K. Shukla et al.
CANCER CELL (2017)
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Cristoforo Grasso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Pancreatic cancer: Stroma and its current and emerging targeted therapies
Janaiah Kota et al.
CANCER LETTERS (2017)
Nanotechnology for delivery of gemcitabine to treat pancreatic cancer
Gebremariam Birhanu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer
Xiangsheng Liu et al.
ACS NANO (2016)
Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
Xiao Zhao et al.
BIOMATERIALS (2016)
Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer
N. V. Rajeshkumar et al.
BRITISH JOURNAL OF CANCER (2016)
Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
Stacey M. Stein et al.
BRITISH JOURNAL OF CANCER (2016)
Characteristics and Significance of the Pre-metastatic Niche
Yang Liu et al.
CANCER CELL (2016)
The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
Saswati Chand et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
Amira Elgogary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies
Tasuku Matsuoka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics
Lili Zou et al.
THERANOSTICS (2016)
Hybrid Nanomaterials Based on Iron Oxide Nanoparticles and Mesoporous Silica Nanoparticles: Overcoming Challenges in Current Cancer Treatments
Merlis P. Alvarez-Berrios et al.
JOURNAL OF CHEMISTRY (2016)
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
Norihiro Sato et al.
ACTA PHARMACEUTICA SINICA B (2016)
Advances in the use of nanocarriers for cancer diagnosis and treatment
Debora Braga Vieira et al.
EINSTEIN-SAO PAULO (2016)
Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
Huan Meng et al.
ACS NANO (2015)
Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer
Xiao Zhao et al.
BIOMATERIALS (2015)
Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer Normalization, Not Destruction
Clifford J. Whatcott et al.
CANCER JOURNAL (2015)
Nanotechnology: Future of Oncotherapy
Kshipra M. Gharpure et al.
CLINICAL CANCER RESEARCH (2015)
Metabolic Dependencies in RAS-Driven Cancers
Alec C. Kimmelman
CLINICAL CANCER RESEARCH (2015)
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
Daniel V. T. Catenacci et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin
Lei Miao et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors
Jie Wang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer
Christopher Poon et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Intelligent nanoparticles for advanced drug delivery in cancer treatment
David S. Spencer et al.
CURRENT OPINION IN CHEMICAL ENGINEERING (2015)
Bundled Assembly of Helical Nanostructures in Polymeric Micelles Loaded with Platinum Drugs Enhancing Therapeutic Efficiency against Pancreatic Tumor
Yuki Mochida et al.
ACS NANO (2014)
Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity
Karlo Perica et al.
ACS NANO (2014)
A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
M. Aglietta et al.
ANNALS OF ONCOLOGY (2014)
SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway
Ting-hua Hu et al.
CANCER LETTERS (2014)
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
Mara H. Sherman et al.
CELL (2014)
Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells
Zhuo-Xin Cheng et al.
ONCOLOGY REPORTS (2014)
Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
Andrew E. Becker et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer
Joshua McCarroll et al.
Frontiers in Physiology (2014)
Nanoparticles for Combination Drug Therapy
Liang Ma et al.
ACS NANO (2013)
Two-Wave Nanotherapy To Target the Stroma and Optimize Gemcitabine Delivery To a Human Pancreatic Cancer Model in Mice
Huan Meng et al.
ACS NANO (2013)
The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression
Saijie Zhu et al.
BIOMATERIALS (2013)
Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy
Andrei Maksimenko et al.
CANCER LETTERS (2013)
A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
Jordan Berlin et al.
CLINICAL CANCER RESEARCH (2013)
Deciphering the role of stroma in pancreatic cancer
Meghna Waghray et al.
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Just getting into cells is not enough: Mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpression
Piyanuch Wonganan et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pancreatic cancer: why is it so hard to treat?
Paul E. Oberstein et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
Silica-based nanoprobes for biomedical imaging and theranostic applications
Juan L. Vivero-Escoto et al.
CHEMICAL SOCIETY REVIEWS (2012)
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Priyambada Parhi et al.
DRUG DISCOVERY TODAY (2012)
The role of transporters in the toxicity of nucleoside and nucleotide analogs
Christopher A. Koczor et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
Yu Sun et al.
NATURE MEDICINE (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Hepatic Stellate Cells: Partners in Crime for Liver Metastases?
Ningling Kang et al.
HEPATOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
Jonathan P. Celli et al.
CHEMICAL REVIEWS (2010)
Curcumin Inhibits the Sonic Hedgehog Signaling Pathway and Triggers Apoptosis in Medulloblastoma Cells
Maha H. Elamin et al.
MOLECULAR CARCINOGENESIS (2010)
Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
Juan L. Vivero-Escoto et al.
SMALL (2010)
In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer
Donato Cosco et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
The metastatic niche: adapting the foreign soil
Bethan Psaila et al.
NATURE REVIEWS CANCER (2009)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
Shin Nakahira et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
分享论文
